Peanut Allergy

Resource Center

Commentary

peanut allergy

Is Peanut Oral Immunotherapy Ready for Prime-Time?

01/15/2022

Derek Chu, MD, PhD, internal medicine specialist at McMaster University in Ontario, Canada, and lead author of the PACE study, discusses the state of available evidence for the benefits and harms of peanut...

01/15/2022

Research Summaries

FDA Alert

FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis

08/19/2024

Anthony Calabro, MA

The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.

08/19/2024

peanut allergy

Adult-Onset Peanut Allergy: What Are the Characteristics?

02/10/2021

Peanut allergies may be a widespread, prevalent occurrence but knowledge gaps remain on peanut allergy in the adult population. In a recent study, researchers examined the prevalence and characteristics of...

02/10/2021

peanut allergy

FDA Panel Recommends Approval of First Therapy for Peanut Allergy

09/16/2019

An FDA advisory committee has recommended the approval of the first therapy for peanut allergies.

09/16/2019

peanut allergy

Oral Immunotherapy Desensitizes Children With Peanut Allergy

11/19/2018

In a recent study, researchers examined the effectiveness of treatment with a peanut-derived investigational biologic oral immunotherapy drug to reduce sensitivity in children and adolescents with severe...

11/19/2018

peanut allergy

Peanut Allergy Unresponsiveness Sustained With Combination Therapy

08/17/2017

Oral immunotherapy may be a possible treatment for food allergies. However, the long-term effects of combined probiotic and oral immunotherapy in individuals with peanut allergy are currently unstudied. ...

08/17/2017

October 2024

Current Issue

October 2024

Volume 64

Issue 9